Natco Pharma Ltd
Boya Venkateswarlu has over 18 years of experience in the pharmaceutical industry, currently serving as Production Manager at NATCO Pharma since March 2018. Previous positions include Team Leader at Mylan Laboratories Limited and Production Executive at Gland Pharma Limited. Boya began a career in production at Indian Immunologicals Limited and gained initial experience as a Trainee at Bharat Biotech International Limited. Academic qualifications include a Master's degree in Microbiology from Acharya Nagarjuna University, an MBA in Operations Management and Supervision from Pondicherry University, and a Bachelor of Science in Microbiology from Sri Krishnadevaraya University.
This person is not in any offices
Natco Pharma Ltd
2 followers
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.